Entera Bio (ENTX) Competitors $2.10 -0.09 (-4.11%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.10 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENTX vs. ACB, TERN, FHTX, TSHA, CYRX, ANNX, CRVS, TRVI, CMPS, and AQSTShould you be buying Entera Bio stock or one of its competitors? The main competitors of Entera Bio include Aurora Cannabis (ACB), Terns Pharmaceuticals (TERN), Foghorn Therapeutics (FHTX), Taysha Gene Therapies (TSHA), Cryoport (CYRX), Annexon (ANNX), Corvus Pharmaceuticals (CRVS), Trevi Therapeutics (TRVI), COMPASS Pathways (CMPS), and Aquestive Therapeutics (AQST). These companies are all part of the "pharmaceutical products" industry. Entera Bio vs. Aurora Cannabis Terns Pharmaceuticals Foghorn Therapeutics Taysha Gene Therapies Cryoport Annexon Corvus Pharmaceuticals Trevi Therapeutics COMPASS Pathways Aquestive Therapeutics Aurora Cannabis (NASDAQ:ACB) and Entera Bio (NASDAQ:ENTX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Do analysts prefer ACB or ENTX? Entera Bio has a consensus price target of $10.00, indicating a potential upside of 376.19%. Given Entera Bio's higher probable upside, analysts plainly believe Entera Bio is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Entera Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, ACB or ENTX? Aurora Cannabis has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, Entera Bio has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Which has stronger valuation & earnings, ACB or ENTX? Entera Bio has lower revenue, but higher earnings than Aurora Cannabis. Entera Bio is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$200.35M1.61-$48.62M$0.05117.82Entera Bio$130K577.98-$8.89M-$0.26-8.08 Does the MarketBeat Community believe in ACB or ENTX? Aurora Cannabis received 205 more outperform votes than Entera Bio when rated by MarketBeat users. However, 67.55% of users gave Entera Bio an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Entera BioOutperform Votes17967.55% Underperform Votes8632.45% Is ACB or ENTX more profitable? Aurora Cannabis has a net margin of 0.42% compared to Entera Bio's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat Entera Bio's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis0.42% 0.59% 0.42% Entera Bio N/A -107.24%-92.29% Does the media favor ACB or ENTX? In the previous week, Aurora Cannabis and Aurora Cannabis both had 2 articles in the media. Entera Bio's average media sentiment score of 1.42 beat Aurora Cannabis' score of 0.50 indicating that Entera Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Entera Bio 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ACB or ENTX? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 14.1% of Entera Bio shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 10.9% of Entera Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryAurora Cannabis beats Entera Bio on 11 of the 17 factors compared between the two stocks. Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENTX vs. The Competition Export to ExcelMetricEntera BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$75.14M$3.12B$5.80B$8.94BDividend YieldN/A1.57%4.78%3.85%P/E Ratio-8.0830.1226.4118.84Price / Sales577.98320.52450.1476.68Price / CashN/A183.5344.0437.47Price / Book5.833.567.634.64Net Income-$8.89M-$71.72M$3.18B$245.69M7 Day Performance-13.58%-2.45%-1.82%-2.59%1 Month Performance-12.50%0.36%0.22%-2.30%1 Year Performance100.00%-11.49%17.25%13.71% Entera Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENTXEntera Bio3.0028 of 5 stars$2.10-4.1%$10.00+376.2%+100.0%$75.14M$130,000.00-8.0820Positive NewsACBAurora Cannabis0.5175 of 5 stars$6.31-4.7%N/A+73.2%$346.17M$200.35M126.231,073Gap UpTERNTerns Pharmaceuticals4.3932 of 5 stars$4.06-0.5%$18.30+350.7%-50.4%$344.86MN/A-3.4440FHTXFoghorn Therapeutics2.7039 of 5 stars$6.13-0.5%$13.17+114.8%-12.4%$340.89M$34.15M-3.19120Positive NewsTSHATaysha Gene Therapies2.5091 of 5 stars$1.63+0.6%$6.63+306.4%-36.1%$334.05M$15.45M2.59180CYRXCryoport2.5802 of 5 stars$6.73+0.4%$12.29+82.6%-61.4%$332.66M$233.26M-1.991,170Positive NewsANNXAnnexon2.5512 of 5 stars$3.07+2.0%$15.80+414.7%-42.8%$327.23MN/A-2.9260News CoverageGap UpCRVSCorvus Pharmaceuticals1.9049 of 5 stars$4.88-0.8%$12.38+153.6%+82.2%$313.59MN/A-5.2530News CoverageTRVITrevi Therapeutics2.7567 of 5 stars$4.07+1.5%$9.31+128.8%+73.6%$312.86MN/A-9.2520News CoveragePositive NewsGap UpCMPSCOMPASS Pathways1.7049 of 5 stars$4.57+3.4%$30.60+569.6%-57.6%$312.68MN/A-2.08120AQSTAquestive Therapeutics2.1557 of 5 stars$3.32-4.3%$11.00+231.3%+19.9%$302.72M$50.58M-7.38160Short Interest ↓Positive News Related Companies and Tools Related Companies Aurora Cannabis Competitors Terns Pharmaceuticals Competitors Foghorn Therapeutics Competitors Taysha Gene Therapies Competitors Cryoport Competitors Annexon Competitors Corvus Pharmaceuticals Competitors Trevi Therapeutics Competitors COMPASS Pathways Competitors Aquestive Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ENTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
